Table 3.
Effects after 12-week training of inflammatory profile between EG (n = 24) and MG (n = 11).
| Baseline | 12 weeks | Effect size | Delta post-pre (95%CI) | p | Effect | p | F | Effect size | ||
|---|---|---|---|---|---|---|---|---|---|---|
| IL-6 (pg/ml) | EG | 2.41 ± 1.55 | 1.42 ± 1.04 | 0.76 | −0.91 [−1.80 to 0.03] | Group | 0.04 | 4.39 | 0.13 | |
| 0.48 | Time | <0.01 | 10.55 | 0.27 | ||||||
| MG | 3.90 ± 2.93 | 2.22 ± 1.80 | 0.71 | −1.66 [−3.91 to 0.58] | Group × time | 0.40 | 0.70 | 0.02 | ||
| TNF-α (pg/ml) | EG | 8.10 ± 10.83 | 4.17 ± 8.15 | 0.41 | −3.45 [−5.88 to −1.03] | Group | 0.31 | 1.05 | 0.03 | |
| 0.44 | Time | <0.01 | 10.55 | 0.28 | ||||||
| MG | 14.14 ± 20.18 | 6.90 ± 7.52 | 0.52 | −8.15 [−18.11 to 1.80] | Group × time | 0.34 | 0.94 | 0.03 | ||
| IL-10 (pg/ml) | EG | 1.64 ± 0.63 | 1.80 ± 1.47 | 0.15 | −0.09 [−0.56 to 0.75] | Group | 0.02 | 5.51 | 0.14 | |
| 0.06 | Time | 0.15 | 2.08 | 0.06 | ||||||
| MG | 3.35 ± 2.60 | 2.30 ± 1.60 | 0.50 | −1.05 [−2.19 to 0.09] | Group × time | 0.06 | 3.03 | 0.16 | ||
| IL-15 (pg/ml) | EG | 57.73 ± 33.12 | 42.75 ± 32.91 | 0.86 | −11.76 [−35.65 to 12.12] | Group | 0.10 | 2.80 | 0.07 | |
| 0.69 | Time | 0.03 | 4.88 | 0.12 | ||||||
| MG | 89.11 ± 100.30 | 65.80 ± 42.23 | 0.33 | −25.73 [−73.08 to 21.62] | Group × time | 0.63 | 0.23 | <0.01 | ||
| IL-10/TNF-α (pg/ml) | EG | 0.42 ± 0.34 | 2.67 ± 4.01 | 1.03 | 2.05 [−0.11 to 4.22] | Group | 0.17 | 1.16 | 0.08 | |
| 0.03 | Time | 0.10 | 2.79 | 0.09 | ||||||
| MG | 0.67 ± 0.68 | 0.63 ± 0.53 | 0.07 | −0.04 [−0.53 to 0.44] | Group × time | 0.09 | 3.03 | 0.10 |
IL-6, Interleukin-6; TNF-α, Tumor necrosis factor-alfa; IL-10, Interleukin-10; IL-15, Interleukin-15; IL-10/TNF-α, Interleukin-10/Tumor necrosis factor-alfa ratio. EG, elastic group; MG, weight machine group. Data expressed as mean and standard deviation; Delta post-pre: difference between the initial and final evaluations of each group expressed as mean and 95% confidence interval.